Literature DB >> 15735169

Myelodysplastic syndrome with erythroid hypoplasia.

R Goyal1, N Varma, R K Marwaha.   

Abstract

The incidence of myelodysplastic syndrome (MDS) with erythroid hypoplasia/aplasia is probably underestimated because in most patients it is mistaken for acquired pure red blood cell aplasia. This report describes three children who fulfilled the criteria for MDS with erythroid hypoplasia/aplasia. All these patients had transfusion dependent anaemia, reticulocytopenia, erythroid hypoplasia/aplasia, severe dysgranulopoiesis, and dysmegakaryopoiesis.

Entities:  

Mesh：

Year:  2005        PMID： 15735169      PMCID： PMC1770594          DOI： 10.1136/jcp.2004.020974

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  12 in total

Review 1.  The biology of pure red cell aplasia.

Authors:  E N Dessypris
Journal:  Semin Hematol       Date:  1991-10       Impact factor: 3.851

2.  Red cell hypoplasia associated with myeloproliferative and myelodysplastic syndrome.

Authors:  M K Cook
Journal:  J Clin Pathol       Date:  1989-08       Impact factor: 3.411

3.  The preleukemic syndrome: clinical and laboratory features, natural course, and management.

Authors:  J W Linman; C Bagby
Journal:  Nouv Rev Fr Hematol Blood Cells       Date:  1976

4.  Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes.

Authors:  Jeffrey J Molldrem; Eric Leifer; Erkut Bahceci; Yogen Saunthararajah; Mary Rivera; Cynthia Dunbar; Johnson Liu; Riotoro Nakamura; Neal S Young; A John Barrett
Journal:  Ann Intern Med       Date:  2002-08-06       Impact factor: 25.391

Review 5.  Myelodysplastic syndrome with erythroid hypoplasia/aplasia: a case report and review of the literature.

Authors:  J García-Suárez; T Pascual; M A Muñoz; B Herrero; A Pardo
Journal:  Am J Hematol       Date:  1998-08       Impact factor: 10.047

6.  Red cell aplasia in myelodysplastic syndrome.

Authors:  P J Williamson; D G Oscier; A J Bell; T J Hamblin
Journal:  J Clin Pathol       Date:  1991-05       Impact factor: 3.411

7.  Red cell hypoplasia, thrombocytosis, and leucocytosis: myelodysplastic and proliferative syndrome.

Authors:  A Craig; C G Geary; E M Love; J Liu-Yin
Journal:  J Clin Pathol       Date:  1988-11       Impact factor: 3.411

8.  5q- syndrome in a child.

Authors:  A Uyttebroeck; P Brock; B De Groote; M Renard; P Dal Cin; H Van den Berghe; M Casteels-Van Daele
Journal:  Cancer Genet Cytogenet       Date:  1995-04

9.  The pathophysiology of pure red cell aplasia: implications for therapy.

Authors:  R J Charles; K M Sabo; P G Kidd; J L Abkowitz
Journal:  Blood       Date:  1996-06-01       Impact factor: 22.113

10.  Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles.

Authors:  J J Molldrem; Y Z Jiang; M Stetler-Stevenson; D Mavroudis; N Hensel; A J Barrett
Journal:  Br J Haematol       Date:  1998-09       Impact factor: 6.998
View more
  2 in total

1.  Clonal hematopoiesis in adult pure red cell aplasia.

Authors:  Naohito Fujishima; Junki Kohmaru; Souichi Koyota; Keiji Kuba; Tomoo Saga; Ayumi Omokawa; Yuki Moritoki; Shigeharu Ueki; Fumihiro Ishida; Shinji Nakao; Akira Matsuda; Akiko Ohta; Kaoru Tohyama; Hiroshi Yamasaki; Kensuke Usuki; Yasuhiro Nakashima; Shinya Sato; Yasushi Miyazaki; Yasuhito Nannya; Seishi Ogawa; Kenichi Sawada; Kinuko Mitani; Makoto Hirokawa
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.379

Review 2.  Autoimmune Complications in Hematologic Neoplasms.

Authors:  Wilma Barcellini; Juri Alessandro Giannotta; Bruno Fattizzo
Journal:  Cancers (Basel)       Date:  2021-03-26       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.